Escondido, CA, United States of America

Michael Borns

USPTO Granted Patents = 13 


Average Co-Inventor Count = 1.4

ph-index = 6

Forward Citations = 258(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Michael Borns: Innovator in DNA Sample Preparation

Introduction

Michael Borns is a notable inventor based in Escondido, California. He has made significant contributions to the field of DNA sample preparation, holding a total of 13 patents. His innovative methods have advanced the techniques used in genetic research and analysis.

Latest Patents

One of Michael's latest patents focuses on transposase-random priming DNA sample preparation. This patent provides a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, typically ranging from about 150 base pairs to 1.5 kilobases in length. The method includes tagging the DNA fragments with a first primer sequence using barcoded transposases, followed by a primer extension reaction to introduce a second primer sequence. This can be achieved using either random or gene-specific primers. Additionally, kits for performing this method are also provided, showcasing the practical applications of his work.

Career Highlights

Throughout his career, Michael has worked with prominent companies in the biotechnology sector. He has been associated with Agilent Technologies, Inc. and Stratagene California, where he has contributed to various innovative projects and advancements in DNA technology.

Collaborations

Michael has collaborated with several professionals in his field, including Holly Hogrefe and Connie Jo Hansen. These collaborations have further enriched his work and contributed to the development of new methodologies in DNA sample preparation.

Conclusion

Michael Borns is a distinguished inventor whose work in DNA sample preparation has had a lasting impact on genetic research. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…